Cyclophosphamide+Velcade+Dexamethasone (CVd), Proteasome Inhibitors (PI), Relapsed Refractory Multiple Myeloma (RRMM), 1 prior line of therapy, Phase 2, Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)
### Instruction:
Identify the study with the following condition. 
### Input:
Cyclophosphamide+Velcade+Dexamethasone (CVd), Proteasome Inhibitors (PI), Relapsed Refractory Multiple Myeloma (RRMM), 1 prior line of therapy, Phase 2, Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) 
### Output:
Popular Name is MUK Five, Study ID is ISRCTN17354232